Resistance Or Defiance The FDA And The 11th Circuit Spar Over Statute On Orphan Drug Statutory Exclusivity

Last September, the 11th Circuit Court of Appeals sided with a challenge to the FDA’s long-standing interpretation of the Orphan Drug Act by...

Related Keywords

United States ,Florida ,Jacobus Ruzurgi ,Becerra Jan ,Jacobu Ruzurgi ,Gabriella Mcintyre ,Georgea Obrien ,Jacobus Pharm ,Natural Resources Defense Council Inc ,See Chevron United Statesa Inc ,See Catalyst Pharms Inc ,Chevron United Statesa Inc ,Catalyst Pharmaceuticals Inc ,More Court Challenges To Orphan Exclusivity ,Council Inc ,Veltrop Harkrider ,Circuit Court ,Jacobus Pharmaceutical Company ,Drug Act Incentivizes Development ,Supreme Court ,Overview Of Catalyst Pharms Inc ,Drug Exclusivity Following Catalyst Pharms Inc ,Catalyst Pharms Inc ,Chevron ,Chad Landmon ,Orphan Drug Act ,Orphan Drug Act Incentivizes Development ,Hatch Waxman Act ,Orphan Drug ,Catalyst Case And The ,Chevron United Statesa ,Resources Defense Council ,Southern District ,Administrative Procedure ,Reform Act ,Drug Act ,Orphan Product ,Biological Products ,Catalyst Pharms ,Orphan Drug Exclusivity Following Catalyst Pharms ,Orphan Exclusivity ,Leaves Rare Disease Sponsors ,Intellectual Property ,